Amoxicillin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01060 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 31 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | polyclonal hyperviscosity syndrome | KG + DL |
| 2 | hyperamylasemia | KG + DL |
| 3 | congenital analbuminemia | KG + DL |
| 4 | blood group incompatibility | KG + DL |
| 5 | premalignant hematological system disease | KG + DL |
| 6 | monoclonal gammopathy | KG + DL |
| 7 | hematological disease associated with an acquired peripheral neuropathy | KG + DL |
| 8 | septicemic plague | KG + DL |
| 9 | congenital hematological disorder | KG + DL |
| 10 | epiglottitis | KG + DL |
| 11 | bubonic plague | KG + DL |
| 12 | laryngitis | KG + DL |
| 13 | pneumococcal meningitis | KG + DL |
| 14 | punctate epithelial keratoconjunctivitis | KG + DL |
| 15 | pneumonic plague | KG + DL |
| 16 | gonococcal urethritis | KG + DL |
| 17 | Ureaplasma urethritis | KG + DL |
| 18 | staphylococcal pneumonia | KG + DL |
| 19 | fungal lung infectious disease | KG + DL |
| 20 | hematopoietic and lymphoid system neoplasm | KG + DL |
| 21 | laryngeal diphtheria | KG + DL |
| 22 | silicotuberculosis | KG + DL |
| 23 | pleural tuberculosis | KG + DL |
| 24 | acute gonococcal endometritis | KG + DL |
| 25 | uterine inflammatory disease | KG + DL |
| 26 | xanthogranulomatous pyelonephritis | KG + DL |
| 27 | non specific chronic endometritis | KG + DL |
| 28 | granulomatous endometritis | KG + DL |
| 29 | pyelitis | KG + DL |
| 30 | urogenital tuberculosis | KG + DL |
| 31 | endometrial disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.